Roundtable

Ep. 3: Time Toxicity, CNS Risk, and Sequencing Strategy in EGFR-Mutant NSCLC

Eric Singhi, MD, Sarah Goldberg, MD, MPH, Fawzi Abu Rous, MD, Julia Rotow, MD, Susan Scott, MD

Ep. 2: Clinical Insights: Proactive Toxicity Management and CNS Control in EGFR-Mutant NSCLC

Eric Singhi, MD, Sarah Goldberg, MD, MPH, Susan Scott, MD, Fawzi Abu Rous, MD, Julia Rotow, MD

Ep. 1: OS Benefit and Patient-Centered Delivery Advances in EGFR-Mutant NSCLC

Eric Singhi, MD, Susan Scott, MD, Sarah Goldberg, MD, MPH, Fawzi Abu Rous, MD, Julia Rotow, MD